NLRP3 and cancer: First, we interrogated the expression of NLRP3, CASP1, and IL‐1β in 90 pediatric ALL PDX samples (Pediatric Preclinical Testing Consortium [PPTC] data set) that served as a platform for choosing the most suitable PDX model to study MCC950 effects on cancer.